Agenda
THE EVENT
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 45 speakers will present a full conference programme covering the following key topics including:
STREAM TITLES
- Biomarker Discovery & Validation Strategies & Regulation
- Companion Diagnostics & Personalized Medicine
- Safety & Biomarkers in Clinical Development
- Enabling Technologies to Maximise Biomarker Identification
- CNS Biomarkers
Day One
Stream One Biomarker Discovery & Validation Strategies and Regulation
- Regulatory challenges / qualification procedures
- Validation challenges identification challenges
- Biomarker classification
- Storage strategies in clinical trials
- Pharmacoeconomics of biomarkers
- How biomarkers fit in the current outsourcing climate
Stream Two Companion Diagnostics and Personalized Medicine
- Biomarkers and companion models link to an economic framework
- Development of companion diagnostics
- Development Through Predictive vs Retrospective Biomarker Analysis
- Challenges in Developing A Clinically Validated Companion Diagnostic
- Co-validation of diagnostic and pharmacological products
- CDX regulatory issues
- Patient segmentation
- Stratified medicine partnerships
Day Two
Stream One Safety and Biomarkers In Clinical Development
- Translating clinical biomarkers into clinical decisions
- Safety biomarkers in drug development & clinical trials
- Liver biomarker case Studies
- Toxicity
- Efficacy prediction & animal models
- Pharmacological biomarkers
Stream Two Enabling Technologies to Maximise Biomarker Identification
- Metabolomics
- Proteomics
- Circulating MicroRNA
- Clinical applications of NGS
- Breath analysis
- Pharmacogenetics
- Epigenomics
- Systems biology approaches to inform clinical studies
- MAQC microarray data
CNS Biomarkers Congress (Day 1 and 2)
- CNS biomarker case studies in AD, Parkinsons, Epiliepsy, MS
- Supporting CNS Drug Development using biomarkers
- Challenges in CNS Biomarkers
- CSF biomarkers
- Industry / Academic collaborations
- Anti amyloid therapies for Alzheimer’s disease
- NeuroImaging
- Technology case studies for CNS
Roundtables
- CNS
- Neurology
- Oncology
- Respiratory
- Inflammation
- Cardiovascular, Metabolic and Endocrine Diseases (CVMED)
